NetScientific Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BN4R5Q82
GBP
0.57
0.03 (6.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Dec 24

  • PRE-TAX PROFIT(Q) At GBP -1.82 MM has Fallen at -53.02%
  • ROCE(HY) Lowest at -18.57%
2

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 15 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

-22.83%

stock-summary
Price to Book

1.01

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
31.03%
0%
31.03%
6 Months
40.74%
0%
40.74%
1 Year
9.62%
0%
9.62%
2 Years
-8.8%
0%
-8.8%
3 Years
-17.39%
0%
-17.39%
4 Years
-47.47%
0%
-47.47%
5 Years
28.09%
0%
28.09%

NetScientific Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
21.52%
EBIT Growth (5y)
-3.49%
EBIT to Interest (avg)
-3.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.08
Tax Ratio
1.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.99
EV to EBIT
-4.28
EV to EBITDA
-4.75
EV to Capital Employed
0.99
EV to Sales
6.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-23.18%
ROE (Latest)
-22.83%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by NetScientific Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is -9.09% vs 175.00% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -27.59% vs -26.09% in Dec 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.00",
          "val2": "1.10",
          "chgp": "-9.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.20",
          "val2": "-2.80",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-0.10",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.70",
          "val2": "-2.90",
          "chgp": "-27.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,482.10%",
          "val2": "-2,736.20%",
          "chgp": "-174.59%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
1.00
1.10
-9.09%
Operating Profit (PBDIT) excl Other Income
-4.20
-2.80
-50.00%
Interest
0.10
0.00
Exceptional Items
-0.30
-0.10
-200.00%
Consolidate Net Profit
-3.70
-2.90
-27.59%
Operating Profit Margin (Excl OI)
-4,482.10%
-2,736.20%
-174.59%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2022 is -9.09% vs 175.00% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -27.59% vs -26.09% in Dec 2021

stock-summaryCompany CV
About NetScientific Plc stock-summary
stock-summary
NetScientific Plc
Pharmaceuticals & Biotechnology
NetScientific PLC is a United Kingdom-based healthcare intellectual property (IP) commercialization company. The Company is focused on technologies and companies that treats chronic disease and improve the health and well-being. The Company funds, develops, and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in United States and Europe with a primary focus on digital health, diagnostics and therapeutics. The Company is an investor providing management support, including technical guidance, administrative support, IP and commercial knowhow. The Company has investments in approximately 15 portfolio companies in the United States, United Kingdom and Israel in industrial high-tech, energy and healthcare. The Company’s subsidiaries include NetScientific UK Limited, NetScientific America, Inc and Glycotest, Inc.
Company Coordinates stock-summary
Company Details
PO Box 76075 , LONDON None : EC3P 3DX
stock-summary
Tel: 44 20 35141800
stock-summary
Registrar Details